Page 22 - FLIPBOOK
P. 22
Patients with pre-existing cardiovascular disease are at risk of new
cardiovascular events.
Risk of All-Cause Mortality in 5077 localized/locally advanced PCa treated Brachytherapy ± Neoadjuvant HT
(median 4 months)
Known coronary heart
No comorbidity One CV risk factor disease resulting in HF or MI
HT: hormone therapy; CV: cardiovascular; HF: heart failure; MI: myocardial infarction.
Nanda et al. JAMA 2009; 302:866-73
